Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127426 trials found · Page 1364 of 6372
-
Can a neck brace improve spine fusion outcomes?
Disease control Recruiting nowPostoperative immobilization with a hard cervical collar following posterior cervical fusion remains common practice despite limited evidence demonstrating improved clinical outcomes. This is a prospective, multi-site, randomized clinical trial evaluating postoperative hard cervi…
Sponsor: Georgetown University • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Which biologic is best for nasal polyps? new study aims to find out
Disease control Recruiting nowThe prevalence of Chronic Sinusitis with Nasal Polyps (CRSwNP) in the United States is estimated at roughly 4%, which equates to over 13 million Americans. Until recently, the only medical treatment options available for patients with CRSwNP were corticosteroids, with surgery res…
Phase 4 • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Stomach balloon aims to help obese patients shed pounds safely
Disease control Recruiting nowTo demonstrate the safety and efficacy of Orbera365 in obese populations to support the registration of Orbera365.
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
BUFF trial: which water pill works best for liver patients?
Disease control Recruiting nowPatients with cirrhosis are frequently hospitalized due to an acute decompensation of their liver disease including bleeding, jaundice, encephalopathy, and volume overload. Volume overload is associated with increased mortality from acute hypoxic respiratory failure, hemorrhage f…
Phase 3 • Sponsor: Stacy Johnson • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug aims to boost exercise and brain power in heart failure
Disease control Recruiting nowThe goal of this clinical trial is to learn if therapy with activin ligand-trap biological therapy (an investigational drug) combined with exercise training can improve exercise capacity and cognitive function in heart failure with preserved ejection fraction (HFpEF). The main qu…
Phase 2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Can cannabis replace opioids for pain? new study aims to find out
Symptom relief Not yet recruitingOur purpose for the study is to find safer, less intrusive, better preforming non-addictive products, as an alternative therapy for pain relief and to help alleviate the opioid epidemic ongoing in America today.
Sponsor: American Association of Sensory Electrodiagnostic Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
New pill could clear psoriasis skin in 12 weeks
Disease control Recruiting nowA Study looking at the safety and efficacy of D-2570 in Participants with Plaque Psoriasis
Phase 2 • Sponsor: InventisBio Co., Ltd • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New hope for bladder cancer patients: radiotherapy trial aims to improve survival and quality of life
Disease control Recruiting nowThe goal of this clinical trial is to improve the quality of life and prolong survival in bladder cancer patients unfit for curative treatment. The trial will compare the survival and symptoms of patients randomized to either local radiotherapy in addition to standard of care or …
Sponsor: Umeå University • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Magnetic brain stimulation shows promise for Parkinson's symptoms
Symptom relief Recruiting nowParkinson's disease (PD) is a brain disorder that causes progressive problems with movement, such as slowness, stiffness, tremor, and difficulty walking. Many people with PD also develop problems with thinking and memory. Current medications can help control movement symptoms but…
Sponsor: San Francisco Neurology and Sleep Center • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New hope for tough blood cancers? early trial launches
Disease control Recruiting nowThe study is being conducted to evaluate the safety and tolerability of HRS-3005. To explore the Maximum Tolerated Dose (MTD, if possible) and the Recommended Phase 2 Dose (RP2D). This study also preliminarily evaluated the efficacy of HRS-3005 in patients with B-cell malignancy.
Phase 1 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Sep 10, 2026 14:00 UTC
-
Second radiation for breast cancer recurrence: a new hope?
Disease control Not yet recruitingThis study is to determine whether acute treatment-associated adverse events following breast re-irradiation with aPBI are acceptably low and to assess local control following breast re-irradiation with aPBI. An exploratory aim is to assess cosmetic outcomes following breast re-i…
Phase 1/2 • Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Massive study aims to end debate: which anesthetic causes less Post-Surgery confusion?
Knowledge-focused Recruiting nowThe results of this study have significant implications for clinical practice and guideline development. The current European guideline on postoperative Delirium prevention (ESAIC 2024) explicitly identifies a lack of large, adequately powered studies comparing different anesthet…
Sponsor: Charite University, Berlin, Germany • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Which home breathing machine best prevents COPD Flare-Ups? major trial launches
Disease control Recruiting nowChronic obstructive pulmonary disease (COPD) is a major public health problem with 212.3 million prevalent cases of COPD worldwide and 3.3 million deaths related to COPD in 2019. Obstructive sleep apnoea (OSA) is the most common sleep disordered breathing. It is estimated that al…
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New drug afimkibart tested for Long-Term arthritis control
Disease control Recruiting nowThe study will evaluate the long-term safety and efficacy of Afimkibart (also known as RO7790121) in participants with moderate to severe Rheumatoid Arthritis (RA) who have an inadequate response or intolerance to tumor necrosis factor (TNF) and/or Janus kinase (JAK) inhibitors, …
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Triple threat: drug cocktail and precision radiation take on tough bile duct cancer
Disease control OngoingThis study aims to evaluate the safety and preliminary efficacy of anlotinib combined with cadonilimab and PULSAR in previously treated advanced unresectable or netastatic biliary tract cancer.
Phase 2 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Can a 6-Minute video ease Chemotherapy's toll?
Symptom relief Recruiting nowThis randomized controlled study aims to evaluate the effect of education delivered using the PechaKucha method on symptom management and quality of life in patients receiving chemotherapy. Participants will be randomly assigned to either an intervention group or a control group.…
Sponsor: Istanbul Aydın University • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC
-
Personalized cell therapy takes on Lung-Lining tumors
Disease control Recruiting nowThis research study aims to evaluate the safety and effectiveness of a novel immunotherapy, Fast TIL, an Adoptive Cellular Therapeutic (ACT), to fight cancer that has spread to the pleura or pleural mesothelioma. The ACT product is created at AHN West Penn using the participant's…
Phase 1 • Sponsor: David Bartlett, MD • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Home workouts and sound waves: a new strategy to fight Age-Related muscle loss
Disease control Recruiting nowSarcopenia is an age-related condition characterized by progressive loss of skeletal muscle mass, muscle strength, and physical performance. It is associated with frailty, falls, disability, reduced independence, lower quality of life, and increased healthcare burden. Despite its…
Sponsor: I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Virtual stenting tech aims to improve heart artery procedures
Disease control Recruiting nowCoronary angiography-guided percutaneous coronary intervention (PCI) remains the standard treatment strategy for patients with coronary artery disease; however, suboptimal post-PCI physiological outcomes remain common and are associated with adverse cardiovascular prognosis. Quan…
Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Could a simple ear stimulation device tame psoriatic arthritis?
Disease control Recruiting nowThis prospective single-center interventional study aims to investigate the effects of transcutaneous auricular vagus nerve stimulation (taVNS) on disease activity, pain, quality of life, autonomic dysfunction symptoms, and inflammatory biomarkers in patients with psoriatic arthr…
Sponsor: Marmara University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC